The phosphoinositide-3-kinase (PI3K)–protein kinase B/Ak strain transforming (PKB/AKT) pathway, which promotes cell growth, survival, and metabolism, is often dysregulated in various cancers, including CSCC [36,37]. This evidence concerns the gene AKT1 and skin squamous cell carcinoma.